• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺癌的肿瘤内异质性和遗传特征。

Intratumoral heterogeneity and genetic characteristics of prostate cancer.

机构信息

Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.

First College of Clinical Medicine, Shanxi Medical University, Taiyuan, Shanxi, China.

出版信息

Int J Cancer. 2020 Jun 15;146(12):3369-3378. doi: 10.1002/ijc.32961. Epub 2020 Mar 25.

DOI:10.1002/ijc.32961
PMID:32159858
Abstract

Prostate cancer is a heterogeneous disease and optimum gene targeting treatment is often impermissible. We aim to determine the intratumoral genomic heterogeneity of prostate cancer and explore candidate genes for targeted therapy. Exome sequencing was performed on 37 samples from 16 patients with prostate cancer. Somatic variant analysis, copy number variant (CNV) analysis, clonal evolution analysis and variant spectrum analysis were used to study the intratumoral genomic heterogeneity and genetic characteristics of metastatic prostate cancer. Our study confirmed the high intratumoral genetic heterogeneity of prostate cancer in many aspects, including number of shared variants, tumor mutation burden (TMB), variant genes, CNV burden, weighted genome instability index (wGII), CNV profiles, clonal evolutionary process, variant spectrum and mutational signatures. Moreover, we identified several common genetic characteristics of prostate cancer. Alterations of DNA damage repair genes, RTK/RAS pathway associated gene RASGRF1 and autophagy gene EPG5 may be involved in tumorigenesis in prostate cancer. CNV burden and DNA damage repair (DDR) genes may be associated with metastasis of prostate cancer.

摘要

前列腺癌是一种异质性疾病,通常无法进行最佳的基因靶向治疗。我们旨在确定前列腺癌的肿瘤内基因组异质性,并探索靶向治疗的候选基因。对 16 名前列腺癌患者的 37 个样本进行了外显子组测序。利用体细胞变异分析、拷贝数变异(CNV)分析、克隆进化分析和变异谱分析,研究转移性前列腺癌的肿瘤内基因组异质性和遗传特征。我们的研究从多个方面证实了前列腺癌的肿瘤内遗传异质性很高,包括共享变异数量、肿瘤突变负担(TMB)、变异基因、CNV 负担、加权基因组不稳定性指数(wGII)、CNV 谱、克隆进化过程、变异谱和突变特征。此外,我们还确定了前列腺癌的一些共同遗传特征。DNA 损伤修复基因、RTK/RAS 通路相关基因 RASGRF1 和自噬基因 EPG5 的改变可能参与了前列腺癌的发生。CNV 负担和 DNA 损伤修复(DDR)基因可能与前列腺癌的转移有关。

相似文献

1
Intratumoral heterogeneity and genetic characteristics of prostate cancer.前列腺癌的肿瘤内异质性和遗传特征。
Int J Cancer. 2020 Jun 15;146(12):3369-3378. doi: 10.1002/ijc.32961. Epub 2020 Mar 25.
2
Multifocal Primary Prostate Cancer Exhibits High Degree of Genomic Heterogeneity.多灶性原发性前列腺癌表现出高度的基因组异质性。
Eur Urol. 2019 Mar;75(3):498-505. doi: 10.1016/j.eururo.2018.08.009. Epub 2018 Sep 1.
3
Spatial Intratumor Genomic Heterogeneity within Localized Prostate Cancer Revealed by Single-nucleus Sequencing.基于单细胞测序的局限性前列腺癌中肿瘤内空间基因组异质性。
Eur Urol. 2018 Nov;74(5):551-559. doi: 10.1016/j.eururo.2018.06.005. Epub 2018 Jun 23.
4
Genomic Analysis of Localized High-Risk Prostate Cancer Circulating Tumor Cells at the Single-Cell Level.单细胞水平局部高危前列腺癌循环肿瘤细胞的基因组分析。
Cells. 2020 Aug 8;9(8):1863. doi: 10.3390/cells9081863.
5
Multiscale heterogeneity in gastric adenocarcinoma evolution is an obstacle to precision medicine.胃腺癌进化中的多尺度异质性是精准医疗的障碍。
Genome Med. 2021 Nov 8;13(1):177. doi: 10.1186/s13073-021-00975-y.
6
Genomic Heterogeneity Within Individual Prostate Cancer Foci Impacts Predictive Biomarkers of Targeted Therapy.个体前列腺癌病灶内的基因组异质性影响靶向治疗的预测性生物标志物。
Eur Urol Focus. 2019 May;5(3):416-424. doi: 10.1016/j.euf.2018.01.006. Epub 2018 Feb 15.
7
The heterogeneity and clonal evolution analysis of the advanced prostate cancer with castration resistance.晚期去势抵抗性前列腺癌的异质性和克隆进化分析。
J Transl Med. 2023 Sep 19;21(1):641. doi: 10.1186/s12967-023-04320-2.
8
Patient-Level DNA Damage and Repair Pathway Profiles and Prognosis After Prostatectomy for High-Risk Prostate Cancer.高危前列腺癌前列腺切除术后患者的 DNA 损伤和修复途径特征与预后。
JAMA Oncol. 2016 Apr;2(4):471-80. doi: 10.1001/jamaoncol.2015.4955.
9
Exome sequencing of prostate cancer supports the hypothesis of independent tumour origins.外显子组测序前列腺癌支持肿瘤独立起源的假说。
Eur Urol. 2013 Feb;63(2):347-53. doi: 10.1016/j.eururo.2012.03.050. Epub 2012 Mar 31.
10
Intratumoral and Intertumoral Genomic Heterogeneity of Multifocal Localized Prostate Cancer Impacts Molecular Classifications and Genomic Prognosticators.多灶性局限性前列腺癌的瘤内和瘤间基因组异质性影响分子分类和基因组预后指标。
Eur Urol. 2017 Feb;71(2):183-192. doi: 10.1016/j.eururo.2016.07.008. Epub 2016 Jul 21.

引用本文的文献

1
FTO-mediated the destabilization of RASGRF1 mRNA impedes thyroid cancer progression and suppresses macrophage M2 polarization.FTO介导的RASGRF1 mRNA去稳定化阻碍甲状腺癌进展并抑制巨噬细胞M2极化。
Cell Biol Toxicol. 2025 Aug 4;41(1):123. doi: 10.1007/s10565-025-10073-z.
2
Generation of prostate cancer assembloids modeling the patient-specific tumor microenvironment.生成模拟患者特异性肿瘤微环境的前列腺癌类器官。
PLoS Genet. 2025 Mar 31;21(3):e1011652. doi: 10.1371/journal.pgen.1011652. eCollection 2025 Mar.
3
Harnessing machine learning to predict prostate cancer survival: a review.
利用机器学习预测前列腺癌生存率:综述
Front Oncol. 2025 Jan 10;14:1502629. doi: 10.3389/fonc.2024.1502629. eCollection 2024.
4
Contemporary Update on Clinical and Experimental Prostate Cancer Biomarkers: A Multi-Omics-Focused Approach to Detection and Risk Stratification.前列腺癌临床与实验生物标志物的当代进展:一种聚焦多组学的检测与风险分层方法
Biology (Basel). 2024 Sep 25;13(10):762. doi: 10.3390/biology13100762.
5
Pre-existing cell subpopulations in primary prostate cancer tumors display surface fingerprints of docetaxel-resistant cells.原发性前列腺癌肿瘤中预先存在的细胞亚群呈现出多西他赛耐药细胞的表面特征。
Cell Oncol (Dordr). 2025 Feb;48(1):205-218. doi: 10.1007/s13402-024-00982-2. Epub 2024 Aug 20.
6
Emerging Perspectives in Zinc Transporter Research in Prostate Cancer: An Updated Review.前列腺癌中锌转运体研究的新视角:最新综述
Nutrients. 2024 Jun 26;16(13):2026. doi: 10.3390/nu16132026.
7
A protein-encoding CCDC7 circular RNA inhibits the progression of prostate cancer by up-regulating FLRT3.一种编码蛋白质的CCDC7环状RNA通过上调FLRT3抑制前列腺癌进展。
NPJ Precis Oncol. 2024 Jan 16;8(1):11. doi: 10.1038/s41698-024-00503-2.
8
Integrating single-cell and bulk RNA sequencing data unveils antigen presentation and process-related CAFS and establishes a predictive signature in prostate cancer.整合单细胞和批量 RNA 测序数据揭示了抗原呈递和过程相关的 CAFS,并在前列腺癌中建立了一个预测性特征。
J Transl Med. 2024 Jan 14;22(1):57. doi: 10.1186/s12967-023-04807-y.
9
Establishment of novel ferroptosis-related prognostic subtypes correlating with immune dysfunction in prostate cancer patients.建立与前列腺癌患者免疫功能障碍相关的新型铁死亡相关预后亚型。
Heliyon. 2023 Dec 9;10(1):e23495. doi: 10.1016/j.heliyon.2023.e23495. eCollection 2024 Jan 15.
10
Heterogeneity of computational pathomic signature predicts drug resistance and intra-tumor heterogeneity of ovarian cancer.计算病理特征的异质性可预测卵巢癌的耐药性和肿瘤内异质性。
Transl Oncol. 2024 Feb;40:101855. doi: 10.1016/j.tranon.2023.101855. Epub 2024 Jan 6.